Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the overall response rate of gemcitabine and vinorelbine combination (GV) and
gemcitabine followed by vinorelbine (G⇒V) when used as palliative therapy in patients with
stage IV and recurrent breast cancer.